Morgan Stanley’s decision to upgrade Honeywell Aerospace to Overweight, with a $205 price target, centers on a striking valuation differential. The firm points out that Honeywell Aerospace is trading at roughly 16.8x 2028 P/FCF compared with a peer median near 25.5x - a gap that Morgan Stanley characterizes as a roughly 35% discount. At a trade price of $172.84, the stock rose 7.51% on the day of the upgrade, though it remains about 27% below its level at the June 29 spin-off.
The valuation case
The upgrade is grounded in straightforward arithmetic. Morgan Stanley’s note emphasizes both P/FCF and EV/EBITDA comparisons where Honeywell Aerospace sits meaningfully below the peer set:
- 2028 P/FCF: ~16.8x for HONA versus ~25.5x peer median - roughly a 35% discount
- 2028 EV/EBITDA: ~11.4x for HONA versus ~18.3x peer median - roughly a 38% discount
On those metrics, Morgan Stanley labels HONA the least expensive large-cap aerospace company covered by the firm, arguing that the market has overreacted to supply disruptions that the bank views as remediable.
Fundamentals that complicate the picture
Not all data align neatly with the bull case. FinQL-sourced figures paint a more complex operational and financial portrait for Honeywell Aerospace at the stated market price of $172.84:
- Market capitalization: $50.95 billion
- P/E LTM: 28.2x
- EV/EBITDA (reported): 19.8x
- Free cash flow: $2.50 billion
- Net margin: 10.9%
Several balance-sheet and market-sentiment items raise caution. The company shows negative book equity, with a debt-to-equity ratio of -283.5%, reflecting the capital structure left after the spin-off. A fair-value model cited at $167.91 implies the stock may already be slightly overvalued versus the current market price. Additionally, nine analysts have cut earnings estimates, revenue and EPS growth read as "NM" - likely influenced by the spin-off - and the company currently pays no dividend, which is notable for a mature aerospace business.
Supply-chain dynamics: temporary bottleneck or deeper problem?
Company management attributes current underperformance primarily to a narrow set of supplier constraints. Management contends that roughly 2% of the supplier base is creating production bottlenecks, and that resolving overdue components from a single supplier - reported at $15-16 million in past-due parts - could free up "hundreds of millions" of revenue. To address these issues, Honeywell Aerospace is deploying more than $1 billion in supply-chain remediation and plans to add 50 additional sources in the first half of 2026.
Bear-case rebuttals highlight timing and comparative-pressure risks. The third quarter presents a difficult year-over-year comparison, since commercial aftermarket revenue expanded 23% in Q3 2025. Management itself admitted it overestimated the pace of the June ramp, underscoring elevated execution risk in the near term.
Does the upgrade hold up?
The Morgan Stanley thesis is defensible in part: the valuation gap is real and unusually wide. The upside to the $205 target equates to approximately 19% from the cited trading level, should the company re-rate toward peer multiples. However, this is a time-phased wager. The bank's optimism depends on an operational recovery that manifests in 2027 and 2028 rather than an immediate rebound in 2026.
Countervailing evidence - negative book equity, a string of downward earnings revisions, and revenue and EPS growth that read as "NM" - suggest the market's skepticism is not purely punitive. Those are structural and execution-related frictions tied to the spin-off that may not be resolved within a single quarter.
Bottom line
Morgan Stanley has made a classic buy-the-dip argument around a recognizable aerospace franchise. The call is logical if one accepts two linked premises: that the supply-chain issues are fixable and that a visible inflection arrives in 2027. The valuation spread grants a degree of margin of safety, but the company’s current balance-sheet configuration and recent analyst downgrades mean the trade carries material execution and structural risk.
Investors weighing the upgrade should treat the call as a medium-term recovery bet rather than a short-term turnaround play.